Gelteq (GELS) Receivables - Net (2023 - 2025)

Gelteq (GELS) recorded quarterly Receivables - Net of $29415.7 in Q2 2025, down 85.25% quarter-over-quarter from $199461.3 in Q4 2024, and down 75.61% on a YoY basis from $120604.8 in Q2 2024.

Gelteq (GELS) Receivables - Net (2023 - 2025) Analysis & Trends

Gelteq's Receivables - Net history runs 3 years deep, the most recent figure standing at $29415.7 for Q2 2025.

  • In Q2 2025, Receivables - Net fell 75.61% year-over-year to $29415.7; the TTM figure through Jun 2025 stood at $29415.7 (down 75.61% YoY), while the FY2025 annual figure was $29415.7, down 75.61% from the prior year.
  • Receivables - Net was $29415.7 for Q2 2025 at Gelteq, down from $199461.3 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $199461.3 in Q4 2024 to a low of $5534.0 in Q2 2023.
  • Historically, Receivables - Net has averaged $88754.0 across 3 years, with a median of $75010.3 in 2025.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Net soared 2079.33% in 2024, then slumped 75.61% in 2025.
  • A 3-year view of Receivables - Net shows it stood at $5534.0 in 2023, then soared by 3504.27% to $199461.3 in 2024, then slumped by 85.25% to $29415.7 in 2025.
  • The last three Receivables - Net figures came in at $29415.7 (Q2 2025), $199461.3 (Q4 2024), and $120604.8 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Gelteq 10.57 Mn 10.34 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 29,415.74
Jun 30, 2025 29,415.74
Dec 31, 2024 199,461.34
Dec 31, 2024 199,461.34
Jun 30, 2024 120,604.78
Jun 30, 2024 120,604.78
Jun 30, 2023 5,534.02
Jun 30, 2023 5,534.02